Stephanie Rodriguez
Family · Corpus Christi, TXNPI 1770134751
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $130,305 of the $159,316 with a category attached, or 81.8%. AbbVie accounts for 91.4% of it on its own, with 44 other manufacturers making up the rest. 2025 is the largest year on record at $105,424, more than ten times the $2,456 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 691 payments — averaging $230.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$146K
- Novo Nordisk$2K
- Corcept Therapeutics$2K
- Lilly USA, LLC$1K
- Medtronic$734
- Nevro Corp.$696
- plus $7K from 39 others
What the payments were for
- Speaking & faculty fees$130,30582%
- Travel & lodging$14,0219%
- Food & beverage$14,9219%
- Education$680%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$88,242
- Korlym$576
- MINIMED 780G$478
- RECORLEV$261
- Omnia$255
- Wegovy$235
- REZDIFFRA$234
- Saxenda$234
- MOUNJARO$226
- Ozempic$217
- Senza$134
- AJOVY$125
- NURTEC ODT$125
- ZEPBOUND$122
- ISTURISA$120
- COREVALVE EVOLUT R$117
- DEXCOM G6 TRANSMITTER$114
- Repatha$103
How this compares
$159,316 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 269 | $326,103 |
| OzempicSemaglutide | 112 | $130,863 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 83 | $91,513 |
| JardianceEmpagliflozin | 59 | $72,496 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 56 | $57,892 |
| TrulicityDulaglutide | 27 | $50,113 |
| FarxigaDapagliflozin Propanediol | 24 | $37,866 |
| JanuviaSitagliptin Phosphate | 16 | $15,165 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 15 | $13,292 |
| Repatha SureclickEvolocumab | 11 | $9,715 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 26 | $2,365 |
| SynthroidLevothyroxine Sodium | 20 | $1,546 |
| Levothyroxine Sodium | 103 | $1,292 |
| Hydrocortisone | 12 | $876 |
| Pioglitazone Hcl | 30 | $481 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $1,421 | $376,216296 claims |
| Novo NordiskOzempic | $2,455 | $130,863112 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $570 | $91,51383 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $652 | $85,78874 claims |
| AstraZenecaFarxiga | $101 | $37,86624 claims |
| MerckJanuvia | $108 | $15,16516 claims |
| AbbVieSynthroid | $145,655 | $1,54620 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $71 | $1,292103 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Corpus Christi
- Katie MontgomeryCorpus Christi$29K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.